Clinical efficacy enhancement of a Chinese herbal injection in the treatment of mycoplasma pneumonia in children A protocol of randomized controlled trial

被引:17
作者
Wang, Mian [1 ]
Li, Hongying [2 ]
Yang, Jialing [3 ]
Wang, Meng [1 ]
Liu, Jie [3 ]
机构
[1] First Peoples Hosp Tianmen City, Tianmen, Peoples R China
[2] Cent Hosp Wuhan, Wuhan, Hubei, Peoples R China
[3] Chongqing Shuangqiao Econ & Technol Dev Zone Peop, Chongqing, Peoples R China
关键词
azithromycin; combination therapy; mycoplasma pneumonia in children; protocol; randomized controlled trial; tanreqing injection; MACROLIDE RESISTANCE;
D O I
10.1097/MD.0000000000025135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mycoplasma pneumonia is a common disease in pediatrics, and macrolides is the first choice for the treatment. However, the increase of antibiotic resistance of macrolides makes it more and more complicated for clinical treatment. Due to the long term treatment of macrolides, it may increase the incidence of nausea, vomiting, abdominal pain, diarrhea, and other gastrointestinal symptoms, vascular phlebitis, liver and kidney function damage. Tanreqing injection, a Chinese herbal extraction injection, has advantages in the treatment of mycoplasma pneumonia in children, and it could improve the curative effect, shortening the course of disease, and reducing the side effects. Yet there is a lack of standard clinical studies to verify it, so this randomized controlled trial (RCT) will evaluate the efficacy and safety of Tanreqing injection combined with azithromycin in the treatment of mycoplasma pneumonia in children. Methods: This is a prospective RCT to study the efficacy and safety of Tanreqing injection combined with azithromycin in the treatment of mycoplasma pneumonia in children. It is approved by the Clinical Research Society of our hospital. According to the 1:1 ratio, the patients will be randomly divided into Tanreqing injection combined with azithromycin group (observation group) and azithromycin group (control group). Duration of hospitalization, clinical improvement 7 days after admission, changing laboratory tests, pulmonary function, immunoglobulin level, and adverse reactions will be compared between the 2 groups. The data will be analyzed by SPSS 16.0 software. Discussion: This study will evaluate the efficacy and safety of Tanreqing injection combined with azithromycin in the treatment of mycoplasma pneumonia in children. The results of this experiment will provide clinical basis for the treatment of mycoplasma pneumonia in children with Tanreqing injection combined with azithromycin.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Comparative efficacy of Chinese herbal injections combined with azithromycin for mycoplasma pneumonia in children: A Bayesian network meta-analysis of randomized controlled trials
    Duan, Xiaojiao
    Wang, Kaihuan
    Wu, Jiarui
    Zhang, Dan
    Liu, Xinkui
    Ni, Mengwei
    Liu, Shuyu
    Meng, Ziqi
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (05) : 675 - 684
  • [2] Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial
    Ping Wang
    Yuanlin Song
    Zhi Liu
    Hui Wang
    Wenke Zheng
    Si Liu
    Zhiqiao Feng
    Jingbo Zhai
    Chen Yao
    Ming Ren
    Chunxue Bai
    Hongcai Shang
    Trials, 17
  • [3] Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial
    Wang, Ping
    Song, Yuanlin
    Liu, Zhi
    Wang, Hui
    Zheng, Wenke
    Liu, Si
    Feng, Zhiqiao
    Zhai, Jingbo
    Yao, Chen
    Ren, Ming
    Bai, Chunxue
    Shang, Hongcai
    TRIALS, 2016, 17
  • [4] Efficacy of Chinese herbal medicine Jiangniaosuan formula for treatment of hyperuricemia: study protocol for a double-blinded non-inferiority randomized controlled clinical trial
    Guo, Yafang
    Lu, Hong
    Gan, Jing
    Li, Dongdong
    Gao, Jiandong
    Zhang, Changming
    TRIALS, 2022, 23 (01)
  • [5] Efficacy of Chinese herbal medicine Jiangniaosuan formula for treatment of hyperuricemia: study protocol for a double-blinded non-inferiority randomized controlled clinical trial
    Yafang Guo
    Hong Lu
    Jing Gan
    Dongdong Li
    Jiandong Gao
    Changming Zhang
    Trials, 23
  • [6] Effects of Shenfu injection on inflammatory factors and immune function in children with Mycoplasma pneumoniae A protocol for a double-blind, randomized controlled trial
    Pei, Honglian
    Ma, Youfeng
    Wang, Lin
    Wang, Liping
    Xu, Li
    Wang, Rong
    MEDICINE, 2021, 100 (42)
  • [7] Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial
    Tian, Xue
    Dong, Lei
    Jiang, Ting-Ting
    Tang, Bo-Hao
    Wang, Ze-Ming
    Wu, Yue-E
    You, Dian-Ping
    Bi, Jing
    Qian, Su-Yun
    Qi, Hui
    Shen, A-Dong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Efficacy and safety of Shenkang injection in the treatment of chronic renal failure A protocol of a randomized controlled trial
    Mei, JuXiang
    Yang, LingLing
    Wang, Deqin
    Wang, HaiXia
    MEDICINE, 2021, 100 (48)
  • [9] Efficacy and safety of electroacupuncture in treatment of cervical spondylosis A protocol of randomized controlled trial
    Zhou, Yazhou
    Wang, Wengang
    Tian, Ke
    Huang, Hui
    Jia, Mengrui
    MEDICINE, 2021, 100 (18) : E25570
  • [10] Efficacy and safety of traditional Chinese medicine combined with azithromycin sequential therapy for mycoplasma pneumonia among children: a meta-analysis of randomized controlled trials
    Lyu, Jing
    Fan, Fei
    Li, Ji
    Wang, Qiong
    Tian, Xue
    Xu, Jiaxing
    Zhang, Si
    Wang, Bo
    FRONTIERS IN PHARMACOLOGY, 2024, 15